Metotrexato en psoriasis moderada-grave: revisión de la literatura y recomendaciones de experto

Edmundson, 1958, Treatment of psoriasis with folic acid antagonists, AMA Arch Derm, 78, 200, 10.1001/archderm.1958.01560080060010 Smith, 2000, Systemic therapy of psoriasis using methotrexate, Skin Therapy Lett., 6, 5 Heydendael, 2003, Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis, N Engl J Med., 349, 658, 10.1056/NEJMoa021359 Flytstrom, 2008, Methotrexate vs. ciclosporin in psoriasis: Effectiveness, quality of life and safety. A randomized controlled trial, Br J Dermatol., 158, 116 Saurat, 2008, Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION), Br J Dermatol., 158, 558, 10.1111/j.1365-2133.2007.08315.x Barker, 2011, Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: Results of an open-label, active-controlled, randomized trial (RESTORE1), Br J Dermatol., 165, 1109, 10.1111/j.1365-2133.2011.10615.x Montaudie, 2011, Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity, J Eur Acad Dermatol Venereol., 25, 12, 10.1111/j.1468-3083.2011.03991.x Paul, 2011, Evidence-based recommendations on conventional systemic treatments in psoriasis: Systematic review and expert opinion of a panel of dermatologists, J Eur Acad Dermatol Venereol., 25, 2, 10.1111/j.1468-3083.2011.03990.x Ficha técnica de Metoject [consultado 31 Ago 2015]. Disponible en: http://www.aemps.gob.es/cima/pdfs//ft/71108/FT_71108.pdf Scottish Intercollegiate Guidelines Network. SIGN 50: A guideline developer's handbook. Edinburgh; 2008 January. Grupo de trabajo sobre GPC. Elaboración de Guías de Práctica Clínica en el Sistema Nacional de Salud. Manual Metodológico. Madrid: Plan Nacional para el SNS del MSC. Instituto Aragonés de Ciencias de la Salud-I+CS; 2007 [consultado Oct 2014]. Disponible en: http://www.guiasalud.es/emanuales/elaboracion/documentos/Manual%20metodologico%20-%20Elaboracion%20GPC%20en%20el%20SNS.pdf Wine-Lee, 2013, From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis, J Am Acad Dermatol., 69, 1003, 10.1016/j.jaad.2013.06.046 Menter, 2009, Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents, J Am Acad Dermatol., 61, 451, 10.1016/j.jaad.2009.03.027 Kazaks, 2010, Effect of oral magnesium supplementation on measures of airway resistance and subjective assessment of asthma control and quality of life in men and women with mild to moderate asthma: A randomized placebo controlled trial, J Asthma., 47, 83, 10.3109/02770900903331127 Binymin, 2001, Late reactivation of spinal tuberculosis by low-dose methotrexate therapy in a patient with rheumatoid arthritis, Rheumatology (Oxford)., 40, 341, 10.1093/rheumatology/40.3.341 Di Girolamo, 1998, Cavitary lung tuberculosis in a rheumatoid arthritis patient treated with low-dose methotrexate and steroid pulse therapy, Br J Rheumatol., 37, 1136, 10.1093/rheumatology/37.10.1136 Smith, 1971, Psoriasis, methotrexate and tuberculosis, Br J Dermatol., 84, 590, 10.1111/j.1365-2133.1971.tb02548.x Kalb, 2009, Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference, J Am Acad Dermatol., 60, 824, 10.1016/j.jaad.2008.11.906 Carretero, 2010, Metotrexato: guía de uso en psoriasis, Actas Dermosifiliogr., 101, 600, 10.1016/j.ad.2010.04.002 Bogas, 2010, Methotrexate treatment in rheumatoid arthritis: Management in clinical remission, common infection and tuberculosis. Results from a systematic literature review, Clin Rheumatol., 29, 629, 10.1007/s10067-010-1380-z Vadillo Font, 2003, Incidence and characteristics of tuberculosis in patients with autoimmune rheumatic diseases, Rev Clin Esp., 203, 178, 10.1016/S0014-2565(03)71232-6 Lamb, 2004, Methotrexate and reactivation tuberculosis, J Am Acad Dermatol., 51, 481, 10.1016/j.jaad.2003.07.023 Weber-Schoendorfer, 2014, No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: An observational cohort study, Rheumatology (Oxford)., 53, 757, 10.1093/rheumatology/ket390 Beghin, 2011, Paternal exposure to methotrexate and pregnancy outcomes, J Rheumatol., 38, 628, 10.3899/jrheum.100600 Pathirana, 2009, European S3-guidelines on the systemic treatment of psoriasis vulgaris, J Eur Acad Dermatol Venereol., 23, 1, 10.1111/j.1468-3083.2009.03389.x Ryan, 2012, Psoriasis and cardiovascular disorders, G Ital Dermatol Venereol., 147, 179 Prodanovich, 2005, Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis, J Am Acad Dermatol., 52, 262, 10.1016/j.jaad.2004.06.017 Micha, 2011, Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease, Am J Cardiol., 108, 1362, 10.1016/j.amjcard.2011.06.054 Boehncke, 2011, Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: Results of a prospective longitudinal observational study, J Eur Acad Dermatol Venereol., 25, 1187, 10.1111/j.1468-3083.2010.03947.x Carretero-Hernandez, 2012, Metotrexato en psoriasis: ¿es necesaria una dosis de prueba?, Actas Dermosifiliogr., 103, 1, 10.1016/j.ad.2011.05.008 Braun, 2008, Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial, Arthritis Rheum., 58, 73, 10.1002/art.23144 Wegrzyn, 2004, Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis, Ann Rheum Dis., 63, 1232, 10.1136/ard.2003.011593 Chiaravalloti, 2014, The use of self-administered subcutaneous methotrexate for the treatment of psoriasis, J Drugs Dermatol., 13, 929 2012 De Jager, 2010, Efficacy and safety of treatments for childhood psoriasis: A systematic literature review, J Am Acad Dermatol., 62, 1013, 10.1016/j.jaad.2009.06.048 Stahle, 2010, Juvenile psoriasis and its clinical management: A European expert group consensus, J Dtsch Dermatol Ges., 8, 812, 10.1111/j.1610-0387.2010.07507.x Ricci, 2009, Long-term survival of methotrexate in psoriatic arthritis, Reumatismo., 61, 125 Gumusel, 2011, Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: A one-blind, randomized study, J Eur Acad Dermatol Venereol., 25, 1080, 10.1111/j.1468-3083.2010.03927.x Nyfors, 1978, Benefits and adverse drug experiences during long-term methotrexate treatment of 248 psoriatics, Dan Med Bull., 25, 208 Shiroky, 1997, The use of folates concomitantly with low-dose pulse methotrexate, Rheum Dis Clin North Am., 23, 969, 10.1016/S0889-857X(05)70369-0 Bressolle, 2000, Folic acid alters methotrexate availability in patients with rheumatoid arthritis, J Rheumatol., 27, 2110 Hoekstra, 2003, Long-term observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis, J Rheumatol., 30, 2325 Hoekstra, 2003, Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis, Ann Rheum Dis., 62, 423, 10.1136/ard.62.5.423 Hornung, 2004, Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement, J Rheumatol., 31, 2374 Niehues, 2005, Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria, Rheumatol Int., 25, 169, 10.1007/s00296-004-0537-y Strand, 2000, Folic acid supplementation and methotrexate efficacy: Comment on articles by Schiff, Emery et al., and others, Arthritis Rheum., 43, 2615, 10.1002/1529-0131(200011)43:11<2615::AID-ANR38>3.0.CO;2-A Hughes, 2006, Folic acid supplementation and methotrexate therapy for psoriasis, J Am Acad Dermatol., 55, 366, 10.1016/j.jaad.2006.01.072 Shea, 2013, Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis, Cochrane Database Syst Rev., 5, CD000951 Baggott, 2009, Methotrexate catabolism to 7-hydroxymethotrexate in rheumatoid arthritis alters drug efficacy and retention and is reduced by folic acid supplementation, Arthritis Rheum., 60, 2257, 10.1002/art.24685 Dogra, 2013, Systemic methotrexate therapy for psoriasis: Past, present and future, Clin Exp Dermatol., 38, 573, 10.1111/ced.12062 Shen, 2012, The use of methotrexate in dermatology: A review, Australas J Dermatol., 53, 1, 10.1111/j.1440-0960.2011.00839.x Mahajan, 2010, Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque-type psoriasis — a randomized single-blinded placebo-controlled study, J Eur Acad Dermatol Venereol., 24, 595, 10.1111/j.1468-3083.2009.03486.x Garces, 2013, The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: A systematic review of the literature with a meta-analysis, Ann Rheum Dis., 72, 1947, 10.1136/annrheumdis-2012-202220 Luber, 2014, Long-term durability and dose escalation patterns in infliximab therapy for psoriasis, J Am Acad Dermatol., 70, 525, 10.1016/j.jaad.2013.10.059 Gladman, 2007, Adalimumab for long-term treatment of psoriatic arthritis: Forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial, Arthritis Rheum., 56, 476, 10.1002/art.22379 Gottlieb, 2012, A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis, Br J Dermatol., 167, 649, 10.1111/j.1365-2133.2012.11015.x Strober, 2009, A series of critically challenging case scenarios in moderate to severe psoriasis: A Delphi consensus approach, J Am Acad Dermatol., 61, S1, 10.1016/j.jaad.2009.03.017 Grozdev, 2011, Psoriasis in the elderly: From the Medical Board of the National Psoriasis Foundation, J Am Acad Dermatol., 65, 537, 10.1016/j.jaad.2010.05.014 Bonifati, 1998, Recognition and treatment of psoriasis. Special considerations in elderly patients, Drugs Aging., 12, 177, 10.2165/00002512-199812030-00002 Fairris, 1989, Methotrexate dosage in patients aged over 50 with psoriasis, BMJ., 298, 801, 10.1136/bmj.298.6676.801 Farrow, 1997, Serum aminotransferase elevation during and following treatment of childhood acute lymphoblastic leukemia, J Clin Oncol., 15, 1560, 10.1200/JCO.1997.15.4.1560 Bessho, 1994, Liver function studies in children with acute lymphocytic leukemia after cessation of therapy, Med Pediatr Oncol., 23, 111, 10.1002/mpo.2950230208 Watanabe, 2012, Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate, Mod Rheumatol., 22, 470, 10.3109/s10165-011-0521-9 Ostuni, 2003, Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate, Ann Rheum Dis., 62, 686, 10.1136/ard.62.7.686 Ito, 2001, Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient, Arthritis Rheum., 44, 339, 10.1002/1529-0131(200102)44:2<339::AID-ANR51>3.0.CO;2-Q Hagiyama, 2004, Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis, Clin Exp Rheumatol., 22, 375 Gwak, 2007, Fatal hepatic failure associated with hepatitis B virus reactivation in a hepatitis B surface antigen-negative patient with rheumatoid arthritis receiving low dose methotrexate, Clin Exp Rheumatol., 25, 888 Cobeta Garcia, 2011, Reactivation of hepatitis B in a patient with spondyloarthritis after the suspension of methotrexate and efficacy of treatment with antivirals in association to adalimumab, Reumatol Clin., 7, 200 Maurer, 1994, The use of methotrexate for treatment of psoriasis in patients with HIV infection, J Am Acad Dermatol., 31, 372, 10.1016/S0190-9622(94)70175-X Masson, 1995, Is HIV infection contraindication to the use of methotrexate in psoriatic arthritis?, J Rheumatol., 22, 2191 Menon, 2010, Psoriasis in patients with HIV infection: From the medical board of the National Psoriasis Foundation, J Am Acad Dermatol., 62, 291, 10.1016/j.jaad.2009.03.047